Purpose: Within a family medicine residency, an outpatient buprenorphine treatment
program was provided for pregnant women who were dependent on opioids. The purpose of …

Objective: To compare maternal and fetal outcomes among dyads prescribed
buprenorphine and naloxone or buprenorphine during pregnancy. Methods: Retrospective …

Background Buprenorphine pharmacotherapy for opioid-dependent pregnant women is
associated with maternal and neonatal outcomes superior to untreated opioid dependence …

Background Opioid agonist therapy is strongly recommended for pregnant persons with
opioid use disorder. Buprenorphine may be associated with more favorable neonatal and …

This study was designed to compare the neonatal abstinence syndrome (NAS) in neonates
of methadone and buprenorphine maintained pregnant opioid-dependent women and to …

This open-label prospective study examined maternal and neonatal safety and efficacy
outcome measures during and following prenatal buprenorphine exposure. Three opioid …

Objectives: To study neonatal outcomes following buprenorphine/naloxone and methadone
exposure during pregnancy. Methods: This study is a retrospective review of clinical and …

Aims This paper reviews the published literature regarding outcomes following maternal
treatment with buprenorphine in five areas: maternal efficacy, fetal effects, neonatal effects …

Objective To examine the maternal course and neonatal outcomes for women using
buprenorphine-naloxone for opioid dependence in pregnancy. Design Retrospective cohort …

Objectives Data regarding treatment outcomes with the use of buprenorphine-naloxone
(BUP-NX) in pregnancy are scarce. The objective of this study is to examine the outcomes in …